More than three hundred (300) health professionals participated in a WEBINARon 12 January 2021 about “COVID-19 antiviral and anti-inflammatory therapy in hospitalized patients: Lessons learned and the State of the Art” organized by the Mozambican Institute of Health Education and Research under the HEPI Program: Health-Professionals Education Partnership Initiative nr.R25TW011216.
The Health Education ParnershipInituattve (HEPI) Program is implemented by MIHER is a partnership between Universidade Eduardo Monlane (UEM) and University of California San Diego(UCSD)and the scope of this WEBINAR was prevention and treatment of SARS-COV-2 infection where MIHER intends to develop training programs and promote refreshment sessions to Medical Doctor and other health professionals, including scientists and researchers.
The WEBINAR had as main speaker the Full Professor Constance Benson, MD and Professor of Medicine and Public Health at the University of California San Diego.
The session took about 2 hours and the orator presented a brief epidemiology inform and an overview of Remdesivir (a drug with antiretroviral action against the new coronavirus) and other antivirals trial results, discussed how far make sense the treatment guidelines and covered other therapies in the outpatient settings.
Remember that the Mozambican Institute of Health Education and Research in partnership with the GILEAD Foundation, a Brazilian philanthropic entity and the University of California San Diego donated Remdesivir (Remidia) to the Ministry of Health of Mozambique last January to support the treatment health professionals who are at the forefront of combating COVID-19 who eventually become infected.
MIHER has organized Webinars and training courses for all health professionals, including scientists and researchers. For more details and information follow our website: www.miher.org and social media: https://web.facebook.com/mihermozambique .
For more details on the topic presented by Prof. Constance Benson find her presentation at http://webclass.miher.org/#.Benson_COVID-19-Treatment-Update-and-Lessons-Learned_Mozambique-2-11-2021-1
Dr. Benson is Professor of Medicine in Infectious Diseases at the University of California, San Diego. Dr. Benson received her MD degree from The Ohio State University College of Medicine in 1978. She was subsequently recruited to UC San Diego in December 2005, joining the staff at UC San Diego Medical Center in January, 2006.
She has served as the Vice Chair and then Principal Investigator and Chair of the NIH/NIAID AIDS Clinical Trials Group Network from 1995 to 2010, overseeing the expansion of that network to become the premier multicenter international HIV/AIDS therapeutic research network in the world. She currently serves as the Principal Investigator of the UC San Diego Department of Medicine HIV/AIDS Clinical Trials Unit and the Director of the UC San Diego AntiViral Research Center (AVRC).
Most recently her research has focused on the treatment and prevention of HIV-associated tuberculosis, the development of rapid, point-of-care diagnostic assays for resource-limited settings, and new antiretroviral drug development., Her contributions to the field of HIV/AIDS are numerous. To date, she has published more than 220 original manuscripts, invited reviews, and book chapters.
Dr. Benson is also the Infectious Disease Trainer andProgram Director and maintains active clinical duties as a subspecialist in Infectious Diseases and HIV care at the UC San Diego Medical Center in San Diego. She and Professor Robert Schooley are mainscientists and mentors who promotedPartnershipMIHER/UCSD initially through Medical Partnership Initiative (MEPI) and now current Health Professional Partnership Initiative (HEPI)